ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yoshikatsu Saiki
Kei Sakuma
Koichi Tabayashi
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshioka, I.
Right arrow Articles by Tabayashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshioka, I.
Right arrow Articles by Tabayashi, K.
Related Collections
Right arrow Pericardium

Ann Thorac Surg 2007;84:864-870
© 2007 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Bioabsorbable Gelatin Sheets Latticed With Polyglycolic Acid Can Eliminate Pericardial Adhesion

Ichiro Yoshioka, MDa,*, Yoshikatsu Saiki, MDb, Kei Sakuma, MDa, Atsushi Iguchi, MDa, Takuya Moriya, MDb, Yoshito Ikada, PhDc, Koichi Tabayashi, MDa

a Department of Cardiovascular Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan
b Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
c Department of Bioenvironmental Medicine, Nara Medical University, Nara, Japan

Accepted for publication April 2, 2007.

* Address correspondence to Dr Yoshioka, Department of Cardiovascular Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan (Email: iyoshi{at}mail.tains.tohoku.ac.jp).


    Abstract
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Background: As an extension of our previous studies on bioabsorbable pericardial substitutes, we have created a new form of gelatin sheets latticed with bioabsorbable polyglycolic acid (PGA). This study was undertaken to evaluate the biomechanical property of the sheet and the preventive effect on pericardial adhesions after pericardial replacement in a canine model before its clinical applications.

Methods: The mechanical property was assessed by measuring tension of suture pull-out at first break test. Fifteen dogs underwent partial pericardial replacement with the bioabsorbable sheets through a left thoracotomy. Macroscopic assessment for severity of adhesions and microscopic evaluation for histologic changes were made at 2, 4, 12, and 24 weeks postoperatively.

Results: The latticed sheets exhibited tenfold higher tension of disruption at the suturing margin compared to our previously developed gelatin sheets (619 ± 141 versus 62 ± 7 gf, p < 0.001), and demonstrated equivalent strength to that of clinically available expanded polytetrafluoroethylene membrane. During rethoracotomy, adhesions between the epicardium and the pericardial substitutes were moderate at the 4-week interval and resolved completely after 12 weeks postoperatively. Inflammatory reaction scores graded into 4 scales on histologic assessment were 2 ± 0.0, 1.6 ± 0.6, and 0.3 ± 0.5 at 4, 12, and 24 weeks, respectively. Inflammatory reaction significantly decreased from the 4-week interval to the 24-week interval after the pericardial replacement (p < 0.05).

Conclusions: The bioabsorbable gelatin sheets latticed with PGA gained improved mechanical properties compared with the previously reported gelatin sheets without impairing its bioabsorbability. The bioabsorbable sheet could eliminate pericardial adhesions after being replaced with regenerated tissue.


    Introduction
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
The development of postoperative pericardial adhesions increases the risk of injury to the heart and great vessels at reoperations [1]. Primary closure of the pericardium is, therefore, recommended to reduce the formation of adhesions between the heart and chest wall [2]. In some patients, autologous pericardium cannot be used for various reasons, and pericardial substitutes are employed to secure safer resternotomy at reoperation.

Several attempts have been made to resolve the problem related to pericardial adhesions after cardiac surgery by using different types of pericardial substitutes, including expanded polytetrafluoroethylene (ePTFE) patches [3, 4], silicone rubber [5], and glutaraldehyde-treated bovine or porcine pericardium xenografts [6–8]. Recently, many authors reported that bioabsorbable patches effectively prevented the formation of pericardial adhesions in their experimental studies [9–11]. However, none of these materials has yet been routinely applicable in the clinical setting, as solid clinical evidence on their beneficial effects is absent.

Previously, we reported that a bioabsobable gelatin pericardial substitute generates less adhesion and inflammatory reaction compared with an ePTFE sheet [9]. Gelatin sheet is, therefore, a promising alternative as a synthetic pericardium. However, it has two substantial drawbacks in structural properties. First, the sheet is too malleable to be easily handled. Secondly, its tensile strength is not high enough to steadily hold sutures to the native pericardium. If the margin of the sheet is disrupted by chance after chest closure, it may migrate into unintended places with heart beating. To overcome these problems, we have created a new form of gelatin sheet latticed with polyglycolic acid (PGA). We have examined its biomechanical property first, and implanted the sheet as a pericardial substitute in a canine model to assess its bioabsorbability and preventive effect on pericardial adhesion.


    Material and Methods
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
In this experiment, dogs were treated in accordance with the Declaration of Helsinki and the "Guiding Principles in the Care and Use of Animals." The experimental and animal care protocol was also approved by the Animal Care Committee of the Tohoku University School of Medicine.

Fifteen dogs weighing from 8 to 27 kg (mean, 12 kg) were used as a pericardial reconstruction model. These animals were observed and sacrificed after 2- to 24-week intervals.

Preparation of Gelatin Sheet Latticed With PGA
Gelatin, type I collagen extracted from porcine skin with the alkaline method, was donated by Nippi (Tokyo, Japan). The latticework was created by multiple PGA threads in perpendicular direction. Each thread was made of four knitted PGA fibers. And each PGA fiber was made of 16 PGA fibrils. The size of each lattice is 2.5 mm by 2.5 mm. After placing the latticed fabric on a polystyrene plate, 5 wt% gelatin aqueous solution was cast and air dried to obtain gelatin and PGA integrated gelatin films of 0.16-mm thick. Cross-linking was introduced by heat treatment at 135°C for 14 hours in a vacuum drier. The sheets were finally sterilized with ethylene oxide gas before use. The sheet was manufactured by Gunze (Kyoto, Japan).

Based on the pilot experiments, we confirmed that it takes 6 weeks for the latticed gelatin sheet to biodegrade (Fig 1).


Figure 1
View larger version (123K):
[in this window]
[in a new window]

 
Fig 1. External appearance of the gelatin sheet with polyglycolic acid incorporated into the sheet as a latticework. Each square is 2.5 x 2.5 mm in size. The sheet is adequately malleable for surgical manipulation, and it can be cut to a desired shape.

 
Tension of Suture Pull-Out at First Break Test
Three materials, namely, a gelatin sheet latticed with PGA, a gelatin sheet, and ePTFE sheet, were evaluated for mechanical property. We selected tension of suture pull-out at first break test as the most clinically relevant tensile strength quantification.

Fifteen samples (5 in each material) were cut to the size of 3 x 3 cm square, and immersed in phosphate-buffered saline at 25°C for 1 hour. Once all the samples were stabilized, a Nescosuture 5-0 Nylon (Alfresa Pharma Corporation, Osaka, Japan) was passed through a sample at 2 mm distance from the margin. They are fixed on the analyzer, EZ-graph (Shimadzu, Kyoto, Japan). The edge of the suture was pulled at 100 mm/min speed until the sample sheet tears at the suturing margin. Maximal tension at disruption was defined as failure force.

Surgical Procedures
An intravenous line and electrocardiographic monitoring were established. Anesthesia was induced with 2.5% sodium thiopental injection at a dose of 25 mg/kg, and maintained with inhaled halothane in oxygen. Mechanical ventilation was instituted with an approximate tidal volume set at 10 mL/kg body weight, with 100% oxygen, at a rate of 8 to 14 cycles per minute. Under sterile conditions, a left lateral thoracotomy incision was made through the fourth or fifth intercostal space. After pericardial fat and feeding vessels were carefully separated and the surface of the pericardium was exposed, a 3 x 3 cm segment of pericardium was excised about 1 cm anterior to the phrenic nerve. After scattering 5 mL of autologous blood into the pericardial defect in an attempt to promote the formation of adhesions [9], a sheet was anchored to the surrounding pericardium with 5-0 Prolene (Ethicon, Somerville, New Jersey) mattress sutures at each corner of the sheet. Prophylactic antibiotics (cefazolin sodium 40 mg/kg) were given intravenously immediately before the operation.

The dogs were sacrificed at 2 to 24 weeks after operation, and the en bloc hearts, including the entire pericardium and left lung, were removed through a median sternotomy incision.

Evaluations
The implanted membranes were retrieved at 2 weeks (n = 1), 4 weeks (n = 3), 12 weeks (n = 5), and 24 weeks (n = 6) after implantation. Adhesion formation was evaluated by macroscopic findings. The degree of adhesion was quantitatively classified from 0 to 3, according to the adhesion score used by Heydorn and colleagues [12]: 0 = no adhesion; 1 = adhesion that could be readily separated by finger dissection; 2 = adhesion of intermediate strength; and 3 = adhesion necessitated sharp dissection.

In each animal, the specimens of the myocardium, epicardium, and pericardium were taken for light microscopic studies. These were fixed in 10% phosphate-buffered formalin, embedded in paraffin, and sectioned at 5 µm. Then, sections were stained with hematoxylin-eosin and elastica-Masson to assess inflammatory reaction along with changes in the pericardial substitutes per se.

Escalating severity of the inflammatory reaction was histopathologically defined by increasing numbers of infiltrating inflammatory cells and inflammatory foci. The inflammatory reaction of each sheet was quantitatively classified from 0 to 3, using the inflammatory reaction score reported by Lu and colleagues [13]: 0 = no cell infiltration; 1 = sparse, focal infiltration of neutrophils, lymphocytes, and plasma cells; 2 = focal infiltration of neutrophils, plasma cells, and lymphocytes; 3 = diffuse infiltration of neutrophils, plasma cells, and lymphocytes. Inflammatory reactions were evaluated by the independent two pathologists, who were masked to the treatment. Quoted scores were the mean of the two scores classified by the pathologists.

Finally, the fibrous membranes regenerated from the gelatin sheet latticed with PGA were harvested 24 weeks after implantation. Immunostaining for cytokeratin and HBME-1 was performed using these samples. Cytokeratin, an intermediate filament, is a constituent of epithelial and mesodermal cells; and HBME-1 has developed as a mesothelial cell marker. The antibodies we used were Pan-keratin (Ventana, Kanagawa, Japan) for cytokeratin and anti HBME-1 antibody (Dako, Kyoto, Japan). The immunostaining process we followed has been reported elsewhere [14, 15].

Statistical Methods
All the results were expressed as mean ± SD. Intergroup comparisons for failure force with tension of suture pull-out at first break test were performed using analysis of variance, and the Scheffe test was conducted as the post-hoc test. Intragroup comparisons for adhesion and inflammatory scores were performed using the corresponding nonparametric test (Mann-Whitney test). A p value of less than 0.05 was considered to denote significance. Analyses were performed with StatMate software (ATMS, Tokyo, Japan).


    Results
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Failure Force
The maximal tension of suture pull-out at failure in the latticed gelatin, gelatin, and ePTFE sheets were 619 ± 141, 62 ± 7, and 547 ± 25 gf, respectively. Tensile strength in the latticed gelatin was, therefore, tenfold of that in nonlatticed gelatin (p < 0.001). There was no statistical difference in failure force between the latticed gelatin and ePTFE sheets.

Macroscopic Findings
After 2 weeks, the gelatin sheet latticed with PGA retained the implanted form and had minimal adhesions between the epicardium and the sheet. This adhesion was easily separated by finger blunt dissection. The surface of the heart was smooth, and the coronary vessels were clearly identifiable (Fig 2A).


Figure 2
View larger version (111K):
[in this window]
[in a new window]

 
Fig 2. Macroscopic findings on the bioabsorbable pericardial substitutes: (A) 2 weeks, (B) 4 weeks, (C) 12 weeks, and (D) 24 weeks after implantation. The gelatin sheet remains in place with the latticework. (A) The sheet was easily separated from the epicardium by finger dissection after the 2-week interval. (B) The internal appearance of the pericardium after blunt dissection at the 4-week interval shows that the outer circumferential area has been absorbed. (C) The bioabsorbable gelatin/PGA sheet has generated no adhesion over the epicardium by 12 weeks after implantation. The sheet has been replaced by a thin membrane. Note the identifiable anatomical structure beneath the sheet unlike the obscured anatomy with thick fibrous tissue commonly seen after ePTFE sheet implantation. (D) By 24 weeks after implantation, the sheet was completely absorbed and replaced with the regenerated pericardium. The surface of the heart was smooth and developed no adhesion or fibrosis. (In each illustration, the arrows indicate the replaced pericardial defect.)

 
After 4 weeks, the sheets were incompletely absorbed and filled with regenerated tissue and could still be visualized only in the center of the replaced area. Among 3 animals, the adhesions were absent in 2 animals and severe in 1 animal. In those 2 animals with no adhesions, the surface of the heart had no recognizable tissue reaction (Fig 2B).

After 12 weeks, the adhesions between the epicardium and the pericardial substitute were none in all five animals. The sheets had been completely absorbed and regenerated with a thin fibrous membrane in 2 animals and in the remaining 3 animals, approximately one fifth of the sheets remained in the center of the replaced area and the remaining peripheral area was regenerated with a thin fibrous membrane. In those 2 animals with diminished sheets, the changes in macroscopic appearance at the surface of the heart were minimal and the underlying structures were identifiable, whereas in those 3 animals with partial absorption of the sheets, the epicardial reaction was moderate and recognition of the underlying structures was impeded by fibrous tissue on the epicardium (Fig 2C).

After 24 weeks, all of the pericardial sheets were absorbed completely and regenerated with a thin fibrous membrane. The adhesions between the pericardial substitute and the epicardium were none or minimal. The fibrous changes at th minimal, and underlying structures was identifiable (Fig 2D).

The adhesion scores are summarized in Table 1 (numbers represent mean ± SD of the adhesion scores). Adhesion formation on the latticed gelatin sheet was significantly less than that on the e-PTFE sheet, at 12 weeks after operation (p < 0.05), when the actual numbers reported in our previous paper were directly compared [9]. In the latticed gelatin group, adhesion formation tended to be less as postoperative time progressed (Table 1).


View this table:
[in this window]
[in a new window]

 
Table 1 Changes in Adhesion and Inflammatory Reaction Score Around Gelatin Sheet With Polyglycolic Acid
 
Microscopic Findings
After 2 weeks, most of the gelatin and PGA remained, and these polymers were surrounded by focally infiltrated inflammatory cells on both the heart surface and pleural side. The epicardium was covered with a thin layer of inflammatory cells. The fibrous connective tissues were observed sparsely between the sheet and the heart (Fig 3A).


Figure 3
View larger version (108K):
[in this window]
[in a new window]

 
Fig 3. Histologic sections of the implanted gelatin sheet (g) latticed with polyglycolic acid (PGA [p]) after (A) the 2-week, (B) the 4-week, (C) the 12-week, and (D) the 24-week interval. (A, B, C: original magnification x40. D: original magnification x100; elastica Masson staining.) (A) The gelatin/PGA sheet remains on the surface of the epicardium with loose adhesion. (B) The gelatin has been partially biodegradated, and the PGA fibers are exposed to the surface and surrounded by inflammatory cells and fibrous connective tissue (arrow heads) after the 4-week interval. (C) By 12 weeks after implantation, there is almost no residual gelatin or PGA. The sheet has been replaced with the bilayer-like fibrous connective tissue (asterisk). The structure beneath the regenerated pericardium in this picture is the lung. (D) At 24 weeks after implantation, the regenerated fibrous connective tissue has matured and has become thinner (asterisk).

 
After 4 weeks, at the site of remaining polymers, the pericardial sheet was flamed in by the two membranes. These membranes were covered with a mesothelium-like cell layer, and focally infiltrated by inflammatory cells. A mild inflammatory response with lymphocytes and giant cells was present adjacent to the material and appeared to be more prevalent at the surroundings of PGA compared with the area of gelatin. The fibrous connective tissues became thicker (Fig 3B).

After 12 weeks, the pericardial substitute turned out to be the bilayered membrane. The most of gelatin and PGA had been absorbed. The inflammatory reaction resolved practically, but PGA was slower than gelatin to be degradated, therefore, some amount of granulous tissue and chronic inflammatory reaction were observed at the site of the remaining PGA. The surface layer of fibrous connective tissue at the membrane seemed to be regenerative autologus pericardium mimicking the native pericardium (Fig 3C).

After 24 weeks, almost no inflammatory reaction was observed. The pericardial substitute had been completely absorbed and regenerated with the thin membrane. The membrane of fibrous connective tissue became thinner (Fig 3D).

The microscopic scores of inflammatory reaction are summarized in Table 1 (numbers represent mean ± SD of inflammatory scores). Inflammatory reaction scores were high at 4 weeks and decreased after 12 weeks. The actual inflammatory reaction scores in the latticed gelatin sheets were equivalent to those in the gelatin sheets without PGA latticework, when compared with the numbers reported in our previous paper [9].

Immunostaining for Cytokeratin and HBME-1
In the regenerated membrane 24 weeks after pericardial replacement with the latticed gelatin sheet, cytokeratin was positive on both epicardial and pleural sides (Fig 4A); HBME-1 was positive on the epicardial side only (Fig 4B). These findings imply that the regenerated membrane bears the characteristics of mesothelium.


Figure 4
View larger version (48K):
[in this window]
[in a new window]

 
Fig 4. (A, B) Immunohistochemical staining of the regenerated pericardium 24 weeks after operation using anticytokeratin antibody and anti-HBME-1 antibody. The cells on the surface layers are positive for cytokeratin (A) and HBME-1 (B). The regenerated pericardium mimics the structure of the native pericardium (original magnification x200).

 

    Comment
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Patients undergoing reoperation are at a higher operative risk than those undergoing initial procedures because of the formation of postoperative adhesions [1]. Many approaches have been used to reduce pericardial adhesions. The materials used to prevent detrimental adhesions are classified into four categories: prosthetic membranes, xenograft membranes, solutions containing pharmacologic agents, and resorbable membranes.

Prosthetic membranes include silicone rubber, ePTFE membrane, polyethylene film, and Dacron mesh [3–5, 16, 17]. Among them, the efficacy of ePTFE membrane is widely recognized; however, its clinical use has been limited by concerns over the permanence of this sheet and extensive inflammatory reaction resulting in formation of a fibrous capsule. This poses a potential problem for pediatric patients as the heart grows, and leaving a foreign body in place per se predisposes patients to infection over time [18]. Furthermore, ePTFE is not transparent and may interfere with visualization of the cardiac architecture covered with fibrous capsule underneath an ePTFE sheet during reoperations. In contrast, the gelatin sheet latticed with PGA is transparent, and did not generate fibrous capsule underneath the sheet during 24 weeks of follow-up. Therefore, anatomy of the heart, specifically location of the coronary artery was distinctively identifiable at reoperation. More to the point, unlike ePTFE sheet, our latticed gelatin sheet did not leave any foreign materials by being replaced with autologus tissue, which is the virtue of bioabsorbable material.

The efficacy of other types of bioabsorbable films made from polylactide [19] and polyethylene glycol mixed with polylactic acid [20] [21] in the prevention of adhesion formation has been reported. As discussed by Okuyama and colleagues [21], a bioabsorbable film may only be required during the initial postoperative period to limit adhesion formation. Similarly, Iliopoulos and coworkers [19] sought to reduce the retrosternal adhesions using polylactide film with different absorption rates. Their examination demonstrated that the film with slower absorption rate tended to be more effective in reducing adhesion formation. The fact may be explained by the presumption that the polylactide film acts as scaffold for tissue regeneration which ultimately eliminate adhesions. Malm and coworkers [22] studied the course of tissue regeneration after implantation of patches made from polyhydroxybutyrate in a sheep model, and found that these patches were effective in reducing the formation of adhesions and preservation of the coronary anatomy. These materials have also functioned as supporting scaffolds for regeneration of the pericardium. However, some polyhydroxybutyrate still resided in the regenerated pericardium, and phagocytosis by macrophage was histologically ongoing in their experiments. Prolonged chronic inflammatory reaction around the pericardial substitute might in return cause adhesions. Hence, with regard to bioabsorbability of the various pericardial substitutes, it is still controversial to define the optimal absorption rate.

We have previously compared gelatin films with L-lactic acid-alpha-caprolactone copolymer (L-C copolymer) films in a canine model, and demonstrated that gelatin is superior to the L-C copolymer sheet in terms of prevention of pericardial adhesion with efficient absorption process and less evoked inflammation [9]. In an attempt to improve mechanical strength of the film to achieve a function as a sufficient barrier without loosing excellent characteristics of the gelatin sheet, we created a new form of bioabsorbable gelatin sheet by adding PGA as a latticework.

In this study, the histologic examination demonstrated that the inflammatory reaction to the latticed gelatin sheet was heterogeneously present and more remarkable around the PGA filaments than the area of remaining gelatin. Hence, the PGA filaments as a latticework evoked inflammatory response on the biodegradable sheet. This augmented inflammatory reaction during early postoperative period could have resulted in more intense adhesion formation. On the contrary, almost no inflammatory reaction was observed at 24 weeks after implantation. This reduced inflammatory reaction at late term might closely be related to diminished adhesion around the latticed gelatin sheet.

We found that the gelatin sheet latticed with PGA had been replaced with autologus membrane by 12 weeks after implantation. The membrane was composed of the bilayered structure mimicking the native pericardium as evidenced by immunostaining for cytokeratin and HBME-1 positve methothelium-like cells. This finding imply that latticed gelatin sheet remained in place for appropriate period of time to act as a scaffold for tissue regeneration. The placement of a biodegradable film between the beating heart and the sternum during the actual human cardiac surgery will probably impose a multiaxial loading condition to the film. Under such condition, degradation or breakdown of the sheet may be accelerated. The optimal absorption time, therefore, has yet to be determined in a clinically relevant setting.

In summary, we have created a new form of bioabsorbable gelatin sheet latticed with PGA. Its mechanical property and characteristics for manipulation have remarkably improved compared with our previously developed gelatin sheet. We confirmed the usefulness of the sheet in a canine pericardial replacement model. The sheet exerted the benefits of bioabsorbale material, elimination of adhesions, and regeneration of autologus tissue, without a side effect.

Limitations
Limitation of this study should be noted. The experimental findings might not be completely reproducible clinically because the epicardial damage in this study was limited, cardiopulmonary bypass was not performed, and bleeding was minimal. In addition, unlike in the human chest, where the heart is fixed in its place by the surrounding pleura, creation of retrosternal adhesions in a canine model is difficult because of the large space between the sternum and the pericardium. In this study, therefore, formation of adhesions between the posterior aspect of the sternum and the pericardium, seen in humans, was not observed.


    References
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 

  1. Yau TM, Borger MA, Weisel RD, Ivanov J. The changing pattern of reoperative coronary surgery: trends in 1230 consecutive reoperations J Thorac Cardiovasc Surg 2000;120:156-163.[Abstract/Free Full Text]
  2. Cunningham Jr JN, Spencer FC, Zeff R, et al. Influence of primary closure of the pericardium after open-heart surgery on the frequency of tamponade, postcardiotomy syndrome, and pulmonary complications J Thorac Cardiovasc Surg 1975;70:119-125.[Abstract]
  3. Revuelta JM, Garcia-Rinaldi R, Val F, Crego R, Duran CM. Expanded polytetrafluoroethylene surgical membrane for pericardial closureAn experimental study. J Thorac Cardiovasc Surg 1985;89:451-455.[Abstract]
  4. Minale C, Hollweg G, Nikol S, Mittermayer C, Messmer BJ. Closure of the pericardium using expanded polytetrafluoroethylene Gore-Tex surgical membrane: clinical experience Thorac Cardiovasc Surg 1987;35:312-315.[Medline]
  5. Laks H, Hammond G, Geha AS. Use of silicone rubber as a pericardial substitute to facilitate reoperation in cardiac surgery J Thorac Cardiovasc Surg 1981;82:88-92.[Abstract]
  6. Gallo JI, Pomar JL, Artinano E, Val F, Duran CM. Heterologous pericardium for the closure of pericardial defects Ann Thorac Surg 1978;26:149-154.[Abstract]
  7. Gallo I, Artinano E, Duran CG. Late clinical results with the use of heterologous pericardium for closure of the pericardial cavity J Thorac Cardiovasc Surg 1985;89:709-712.[Abstract]
  8. Yakirevich VS, Abdulali SA, Abbott CR, Ionescu MI. Reconstruction of the pericardial sac with glutaraldehyde-preserved bovine pericardium Tex Heart Inst J 1984;11:238-242.[Medline]
  9. Sakuma K, Iguchi A, Ikada Y, Tabayashi K. Closure of the pericardium using synthetic bioabsorbable polymers Ann Thorac Surg 2005;80:1835-1840.[Abstract/Free Full Text]
  10. Tsukihara H, Takamoto S, Kitahori K, et al. Prevention of postoperative pericardial adhesions with a novel regenerative collagen sheet Ann Thorac Surg 2006;81:650-657.[Abstract/Free Full Text]
  11. Mitchell JD, Lee R, Hodakowski GT, et al. Prevention of postoperative pericardial adhesions with a hyaluronic acid coating solutionExperimental safety and efficacy studies. J Thorac Cardiovasc Surg 1994;107:1481-1488.[Abstract/Free Full Text]
  12. Heydorn WH, Daniel JS, Wade CE. A new look at pericardial substitutes J Thorac Cardiovasc Surg 1987;94:291-296.[Abstract]
  13. Lu JH, Chang Y, Sung HW, et al. Heparinization on pericardial substitutes can reduce adhesion and epicardial inflammation in the dog J Thorac Cardiovasc Surg 1998;115:1111-1120.[Abstract/Free Full Text]
  14. Malm T, Bowald S, Bylock A, Saldeen T, Busch C. Regeneration of pericardial tissue on absorbable polymer patches implanted into the pericardial sacAn immunohistochemical, ultrastructural and biochemical study in the sheep. Scand J Thorac Cardiovasc Surg 1992;26:15-21.[Medline]
  15. Bateman AC, al-Talib RK, Newman T, Williams JH, Herbert A. Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME-1 expression Histopathology 1997;30:49-56.[Medline]
  16. Meus PJ, Wernly JA, Campbell CD, et al. Long-term evaluation of pericardial substitutes J Thorac Cardiovasc Surg 1983;85:54-58.[Abstract]
  17. Bunton RW, Xabregas AA, Miller AP. Pericardial closure after cardiac operationsAn animal study to assess currently available materials with particular reference to their suitability for use after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990;100:99-107.[Abstract]
  18. Calligaro KD, Westcott CJ, Buckley RM, Savarese RP, DeLaurentis DA. Infrainguinal anastomotic arterial graft infections treated by selective graft preservation Ann Surg 1992;216:74-79.[Medline]
  19. Iliopoulos J, Cornwall GB, Evans RO, et al. Evaluation of a bioabsorable polylactide film in a large animal model for the reduction of retrosternal adhesions J Surg Res 2004;118:144-153.[Medline]
  20. Okuyama N, Rodgers KE, Wang CY, et al. Prevention of retrosternal adhesion formation in a rabbit model using bioresorbable films of polyethylene glycol and polylactic acid J Surg Res 1998;78:118-122.[Medline]
  21. Okuyama N, Wang CY, Rose EA, et al. Reduction of retrosternal and pericardial adhesions with rapidly resorbable polymer films Ann Thorac Surg 1999;68:913-918.[Abstract/Free Full Text]
  22. Malm T, Bowald S, Bylock A, Busch C. Prevention of postoperative pericardial adhesions by closure of the pericardium with absorbable polymer patchesAn experimental study. J Thorac Cardiovasc Surg 1992;104:600-607.[Abstract]



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
J. B. Lopes, L. A.O. Dallan, S. P. Campana-Filho, L. A.F. Lisboa, P. S. Gutierrez, L. F. P. Moreira, S. A. Oliveira, and N. A.G. Stolf
Keratinocyte growth factor: a new mesothelial targeted therapy to reduce postoperative pericardial adhesions
Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 313 - 318.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
G. Matsumura, T. Shin'oka, Y. Ikada, T. Sakamoto, and H. Kurosawa
Novel Anti-Adhesive Pericardial Substitute for Multistage Cardiac Surgery
Asian Cardiovasc Thorac Ann, August 1, 2008; 16(4): 309 - 312.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yoshikatsu Saiki
Kei Sakuma
Koichi Tabayashi
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshioka, I.
Right arrow Articles by Tabayashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshioka, I.
Right arrow Articles by Tabayashi, K.
Related Collections
Right arrow Pericardium


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS